Learn How PCF Research Saves Men's Lives
Get the Free 2018 Prostate Cancer Patient Guide (emailed or mailed)
We are in a race for patients. For your husbands and fathers. For your sons ... and now your daughters.
FDA approves Abiraterone + Prednisone for Earlier Treatment of Metastatic Prostate Cancer
Prostate Cancer Screening and You
Nobody wants to think about cancer, especially prostate cancer. Nobody wants to get screened, and especially, nobody wants to even think about getting a rectal exam to check for prostate cancer. We get that.
Precision ScreeningWhen Treatment Stops Working: Blame Resistance
In the upside down world of prostate cancer, the good guys want to win the war and the bad guys are leading the resistance. Imagine Rick’s Café in Casablanca, except it’s the bad guys, with a...
Genetic CounselingImmunotherapyTake Back Your Sex Life
Surgery or radiation treatment for localized prostate cancer doesn’t mean that your sex life has to be over. But a big part of this may be up to you – and it’s not just that part....
Side EffectsAfrican-American? What You Need to Know About Prostate Cancer
In the United States, men of African descent are more likely to develop prostate cancer than any other race or ethnicity.
African Descent
PCF identifies the most promising research ideas and attracts brilliant individuals and teams of scientists, early in their careers, to PCF’s Research Enterprise. By channeling resources directly to the world’s top scientific minds, PCF is able to cut through red tape, speed scientific breakthroughs and deliver new treatments to patients.
For Researchers
The Prostate Cancer Foundation (PCF) is the world's leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised more than $670 million and provided funding to more than 2,000 research programs at nearly 200 cancer centers and universities. The PCF global research enterprise now extends to 19 countries. PCF advocates for greater awareness of prostate cancer and more efficient investment of governmental research funds for transformational cancer research. Its efforts have helped produce a 20-fold increase in government funding for prostate cancer.
Learn more about our foundation